UHS
50
4
SJM
17
5
NEE
39
9
ES
12
3
WBA
41
3
AMAT
33
3
PX
56
3
AMG
33
-11
AZO
46
3
LB
16
9
ADBE
50
3
HAL
40
11
FSLR
50
6
HIG
48
5
WM
53
2
AES
47
4
VRSN
59
4
STT
48
4
MDT
59
4
PEP
33
4
UHS
50
4
SJM
17
5
NEE
39
9
ES
12
3
WBA
41
3
AMAT
33
3
PX
56
3
AMG
33
-11
AZO
46
3
LB
16
9
ADBE
50
3
HAL
40
11
FSLR
50
6
HIG
48
5
WM
53
2
AES
47
4
VRSN
59
4
STT
48
4
MDT
59
4
PEP
33
4
Financhill
Back

Addex Therapeutics 10K Form

Sell
36

ADXN
Addex Therapeutics

Last Price:
$8.16
Seasonality Move:
38.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADXN News And Ratings

See the #1 stock for the next 7 days that we like better than ADXN

ADXN Financial Statistics

Sales & Book Value

Annual Sales: $1.8M
Cash Flow: $-713.3K
Price / Cash Flow: 0
Annual Sales: $12.30
Price / Book: 0.64

Profitability

EPS (TTM): -0.34150
Net Income (TTM): $5.7M
Gross Margin: $2.6M
Return on Equity: 91.08%
Return on Assets: 62.62%

Addex Therapeutics Earnings Forecast

Key Addex Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 8 years for ADXN is 91.70%.
  • The Selling, General & Administrative Expenses for ADXN have been equal to 446.69% of Gross Profit Margin.
  • The Research & Development expenses have been 170.40% of Revenue.
  • The Interest Expense is -0.20% of Operating Income.
  • The Net Earning history of ADXN is -654.47% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 13 years.

Addex Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADXN
Website: addextherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.59
Quick Ratio: 4.36

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADXN Technical Analysis vs Fundamental Analysis

Sell
36
Addex Therapeutics (ADXN) is a Sell

Is Addex Therapeutics a Buy or a Sell?